Here we are at the midpoint of 2006 already. The first half stock market doesn't look pretty! The Dow is up a modest 4%. Two months ago, the Dow was up twice that level but took a tumble in May falling sharply in June and beginning to bounce back in July. The NASDAQ has really taken a hit in these first 6 months, having dropped 2%.
We all know about continue......Full article >>>
$2.7 billion. Imagine what will happen with Pfizer's Lipitor with last year's sales of $13 billion (granted this is worldwide and Pfizer's patent expiration in different parts of the world varies).
More recently, during the last 3 years, Big Pharma has experimented with a different formula called "authorized generics". Under this scenario, in advance of patent expiration, Big Pharma has ......Full article >>>
, and the completion of the Boston Scientific/Abbott Lab's acquisition of Guidant (with Abbott acquiring an equity chunk of Boston Scientific in the process). Of note, in the last week was the disposal by Pfizer of its consumer products business to J&J for over $7 billion. This includes products like Listerine and other products Pfizer had obtained in the Warner-Lambert acquisition along with Pfiz......Full article >>>
|7. Merck (MRK)||$36.43||$31.99||+14%||$ 79.5|
|8. Abbott Labs (ABT)||$43.61||$46.50||<4%>||$ 66.6|
|9. Eli Lilly (LLY)||$55.27||$56.77||<3%>||$ 62.5|
|10. Wyeth (WYE)||$44.4......|
Full article >>>
han the NASDAQ and AMEX Biotech indices. Not a pretty first half!
Big biotech stock performance 2006
|Biotech Company/Ticker||Stock Price June 30, 2006||Stock Price Jan.2, 2006||%Change||Market Cap(S B)|
|NASDAQ Biotech Index||742.87||795.32......|
Full article >>>
period and shut for 1-2 years. The current IPO window has lingered open since the 4th quarter of 2004; however it has not been a strong market, with low initial pricings and valuations. Nevertheless, it continues to remain open! We will look at this further in weeks to come!
One issue that both Big Pharma and biotech companies face: increasing resistance to high pricing on new ......
Full article >>>
Source:wistechnology.com By Michael Rosen 07/03/06
Related biology technology :
1. The Genesis of Gendicine: The Story Behind the First Gene Therapy
2. Business Objects to acquire La Crosse-based Firstlogic
3. Pitney Bowes and Firstlogic cancel acquisition plans
4. Tech Digest: Fiserv, IMS, Honeywell HomMed, Firstlogic
5. Tech Digest: Firstlogic, Fiserv, Red Prairie, Spectrum Brands, Associated Bank
6. J.J. Keller, Modine Manufacturing, Gustave A. Larson Co., Esker, Firstlogic, Software One
7. Pitney Bowes to acquire Firstlogic
8. Firstlogic, Informatica expand OEM partnership
9. Crate and Barrel deploys Firstlogics Information Quality Suite
10. Merkle selects Firstlogic data quality software
11. First pieces of Antarctic deep-space particle detector are in place
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. 25, ... HART ), a biotechnology company developing bioengineered organ ... Jim McGorry will present at the LD Micro ... at 2:30 p.m. PT. The presentation will be webcast ... days. Management will also be available at the conference ...
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/25/2015)... Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... in a fireside chat discussion at the Piper Jaffray ... . The discussion is scheduled for Wednesday, December ... www.orexigen.com . A replay will be available for 14 ... , Julie NormartVP, Corporate Communications and Business Development ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman ... AngelList early in their initial angel funding process. Now, they are paying it ... to make early stage investments in the microbiome space. In this, they ... Breaking Biology Technology:
(Date:11/12/2015)... Nov. 11, 2015 Growing need for ... tools has been paving the way for use ... of discrete analytes in clinical, agricultural, environmental, food ... predominantly used in medical applications, however, their adoption ... due to continuous emphasis on improving product quality ...
(Date:11/10/2015)... 10, 2015 In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/9/2015)... Nov. 09, 2015 ... of the "Global Law Enforcement Biometrics ... --> http://www.researchandmarkets.com/research/52ggmn/global_law ) has announced ... Enforcement Biometrics Market 2015-2019" report to ... Markets ( http://www.researchandmarkets.com/research/52ggmn/global_law ) has announced the ... Breaking Biology News(10 mins):